Status:
RECRUITING
Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)
Lead Sponsor:
National Cancer Centre, Singapore
Conditions:
Neoplasms
Eligibility:
All Genders
21-120 years
Phase:
NA
Brief Summary
The current interdisciplinary specialist palliative care model focuses on supporting patients with advanced cancer who have complex problems in the last weeks of life. Consequently, palliative care is...
Detailed Description
To evaluate the effectiveness of the ENABLE-SG model, we will conduct a randomized wait-list controlled trial comparing clinical outcomes at 6 months between patients and caregivers receiving early EN...
Eligibility Criteria
Inclusion
- Inclusion criteria for patients:
- Adult aged 21 and above
- Within 60 days of being informed of an advanced cancer diagnosis, defined as metastatic or recurrent/ progressive Stage III/IV solid tumour
- Able to speak English or Chinese
- Able to provide informed consent
- Patients will NOT need to have a caregiver willing to participate in the ENABLE-SG programme.
- Inclusion criteria for caregivers:
- Adult aged 21 and above
- Self-endorsing or identified by the enrolled patient as an unpaid spouse/partner, relative or friend who knows them well and who provides regular support (at least 7 hours a week) due to their cancer and who does not have to live in the same dwelling
- Caring for a patient with advanced cancer (see definition under patient inclusion criteria above)
- Able to speak English or Chinese.
- Able to provide informed consent
- Inclusion criteria for healthcare professions:
- 21 years or older.
- Approached to participate in the ENABLE-SG study
- Able to provide informed consent
Exclusion
- Exclusion criteria for patients:
- Medical record documentation of an active severe mental illness, dementia, active suicidal ideation, uncorrected hearing loss
- Unable to complete patient-reported outcome measures
- Has been reviewed by palliative care services in the current model of palliative care.
- Exclusion criteria for caregivers:
- Self-reported severe mental illness, dementia, active suicidal ideation, uncorrected hearing loss
- Unable to complete caregiver-reported outcomes.
- Exclusion criteria for healthcare professional:
- Healthcare professionals that are not providing care for cancer patients.
- Unable to complete interviews.
Key Trial Info
Start Date :
December 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
715 Patients enrolled
Trial Details
Trial ID
NCT06044441
Start Date
December 26 2023
End Date
June 1 2026
Last Update
June 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Centre Singapore
Singapore, Singapore, 168583